3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Tract Infections
1
Urinary Bladder, Neurogenic
1
Spinal Cord Injuries
1
Myelitis, Transverse
1
Multiple Sclerosis
1
Interventions
Fosfomycin
2
Amikacin
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Povidone-Iodine
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Ofloxacin
1
OM 89
1
Nitrofurantoin
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Levofloxacin
1
Labetalol
1
Haloperidol
1
Ertapenem
1
Clozapine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Urinary Tract Infections
×
OM 89
×
Clear all
NCT02591901
2020-03-18
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Phase 2
Completed
48 enrolled